Detroit Cardiologists
Get Directions Southfield - (248) 424-5000   15565 Northland Drive | Suite 108E | Southfield, MI 48075 Hours | Mon – Sat | 7:30 am – 5:00 pm Toll Free | (855) 543-2783   (855) 5-HEARTDOCS - Fax | (248) 424-5099 Doctors Available 24/7 for Emergencies | (313) 222-0330
Detroit Heart Doctors
Get Directions Dearborn - (313) 791-3000 Dearborn Professional Building 2421 Monroe Street | Suite 101 | Dearborn, MI 48124 Hours | Mon – Sat | 7:30 am – 5:00 pm Toll Free | (855) 543-2783   (855) 5-HEARTDOCS - Fax | (313) 791-2800 Doctors Available 24/7 for Emergencies | (313) 222-0330
Detroit Heart Surgeons
Get Directions Detroit - (313) 993-7777   4160 John R Street | Suite 510 | Detroit, MI 48201 Hours | Mon – Sat | 7:30 am – 5:00 pm Toll Free | (855) 543-2783   (855) 5-HEARTDOCS - Fax | (313) 993-2563 Doctors Available 24/7 for Emergencies | (313) 222-0330
  • More
  • Southfield
    (248) 424-5000
  • More
  • Dearborn
    (313) 791-3000
  • More
  • Detroit
    (313) 993-7777
24/7 EMERGENCY (313) 222-0330

Press Release

Press Releases

Drug-Coated Balloon for Treatment of Peripheral Arterial Disease

Read the full article here!

DMC Cardiovascular Institute at Harper University Hospital Receives Carotid Stenting Accreditation

Media Contact:
Sarah Collica
(o) 313.578.2775
(c) 248.459.4669

Detroit, Mich. November 14, 2013—The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) at Harper University Hospital has been granted a three-year term of accreditation in Carotid Stenting by the Intersocietal Accreditation Commission (IAC). CVI is one of only six in the country to receive accreditation.

“At the DMC, cardiovascular health is one of our top priorities,” said Dr. Ted Schreiber, President of DMC CVI. “As we continue to grow our services in anticipation of our 2014 heart hospital opening, we welcome any opportunity--such as this accreditation--to take our expertise to the next level, to then provide for our patients.”

Accreditation by the IAC means that DMC Cardiovascular Institute has undergone a thorough review of its operational and technical components by a panel of experts in the field of Carotid Stenting. The IAC grants accreditation only to those facilities that are found to have processes in place to ensure quality patient care, in compliance with national standards. The IAC’s comprehensive application process includes a detailed procedure review.

"This unique accreditation validates our commitment to quality and safety. This is a badge of honor representing the highest standard in carotid stenting,” said Dr. Mahir Elder, DMC Medical Director of Endovascular Medicine, and Medical Director of Cardiac Care Unit. “The IAC accreditation, volume, and good quality outcomes, make CVI the leader in the State of Michigan and among the highest in the nation." 

Decreased blood flow to the brain caused by plaque on the inside of the carotid arteries is a serious cardiovascular condition that may lead to stroke. Carotid Stenting is a therapeutic procedure used at the site of the blockage to provide support to keep the artery open. Carotid Stenting, a moderately invasive procedure, may be considered an alternative to carotid surgery in some patients. While Carotid Stenting can be extremely beneficial in reducing the risk of stroke due to carotid artery disease, the effectiveness of the procedure is significantly impacted by the performing facility’s adherence to benchmarks related to standards defining optimal resources, training and outcomes.

Founded in 1985, the Detroit Medical Center (DMC) is a leading regional healthcare system with a mission of excellence in clinical care, research and medical education—DMC Children’s Hospital of Michigan with nine specialties centers, DMC Detroit Receiving Hospital, DMC Harper University Hospital, DMC Huron Valley-Sinai Hospital, DMC Hutzel Women’s Hospital, DMC Rehabilitation Institute of Michigan with more than 30 outpatient locations, DMC Sinai-Grace Hospital, DMC Surgery Hospital, and DMC Cardiovascular Institute with new heart hospital coming in 2014. DMC is proud to be the official Healthcare Services Provider of the Detroit Tigers, Detroit Red Wings, Detroit Pistons, Detroit Grand Prix and the Detroit Free Press Marathon, with six DMC Sports Medicine clinics and Sports Performance Academy locations. For more information, visit

Covidien Introduces Rapid Exchange Balloon Engineered for Use Below the Knee

New RapidCrossTM balloon combines rapid exchange convenience and kink-resistant pushability

PLYMOUTH, MN - April 25, 2013 - Covidien, a leading global provider of healthcare products, today launched the RapidCrossTM balloon, a rapid exchange (RX) balloon designed exclusively for below-the- knee (BTK) interventions.

Unlike some competitive products, the new RapidCross balloon is not a coronary device retrofitted for use below the knee. Every detail – including the low profile tip, the robust RX port and the long catheter length – was designed for BTK use. The RapidCross balloon complements Covidien’s NanoCrossTM over-the-wire balloon line for BTK solutions.

“The RapidCross balloon helps reduce procedure time with the convenience of rapid exchange. Even more important is the length of the balloon’s RX port, which allows you to access taller patients and go deeper into the arch,” said Dr. Mahir Elder, interventional cardiologist at Heart and Vascular Institute in Dearborn, Michigan. “With the extended shaft length, long RX port and excellent pushability, this is the best RX BTK balloon I have used.”

The balloon delivers smooth crossing, with its proprietary lubricious coating, and two-to-three-times faster deflation than competitive products, for increased efficiency. To address the common problem of kinking in BTK lesions, Covidien designed this balloon with a unique in-line RX port for optimal kink resistance. It is the only BTK balloon that has 170 cm working length on a tapered balloon, offering improved distal access.

“The RapidCross balloon was explicitly designed to meet the unique needs of BTK interventions, supporting Covidien’s commitment to delivering meaningful innovation,” said Dr. Mark Turco, Chief Medical Officer, Vascular Therapies, Covidien. “This balloon enables physicians to treat more challenging BTK lesions with increased confidence, convenience and efficiency.”


Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit to learn more about our business.

David T. Young
Manager, External Communications
Vascular Therapies

Bruce Farmer
Vice President
Public Relations

Detroit Heart Doctors